Nitric oxide metabolites and erythrocyte deformability in a group of subjects with obstructive sleep apnea syndrome

B. Canino, E. Hopps, V. Calandrino, R. Lo Presti, M. Montana, G. Caimi (Palermo, Italy)

Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing
Session: Of mice and men: physiology and biology of sleep disordered breathing
Session type: Poster Discussion
Number: 1533
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Canino, E. Hopps, V. Calandrino, R. Lo Presti, M. Montana, G. Caimi (Palermo, Italy). Nitric oxide metabolites and erythrocyte deformability in a group of subjects with obstructive sleep apnea syndrome. Eur Respir J 2014; 44: Suppl. 58, 1533

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled nitric oxide is not altered in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring II
Year: 2007


Nitric oxide in airways of patients with obstructive sleep apnea
Source: Eur Respir J 2005; 26: Suppl. 49, 356s
Year: 2005

Severity of obstructive sleep apnea and oxidative stress
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

Diurnal variation of exhaled nitric oxide in obstructive sleep apnea syndrome and healthy subjects
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Concentration of exhaled nitric oxide (FENO) in patients with obstructive sleep apnea
Source: Eur Respir J 2004; 24: Suppl. 48, 118s
Year: 2004

Interrelationships between oxidative stress and MMP-9 in subjects with severe obstructive sleep apnea syndrome
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016


Oxydative stress in obstructive sleep apnea: Value of fractional exhaled nitric oxide measurement
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018

Oral nitric oxide in obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Nitric oxide and obstructive sleep apnea syndrome (OSAS): reflection of inflammation and oxidative stress
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Increased alveolar nitric oxide by trumpet model in patients with obstructive sleep apnoea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Obstructive sleep apnoea, inspiratory flows and exhaled nitric oxide
Source: Eur Respir J 2006; 28: Suppl. 50, 415s
Year: 2006

Fractional exhaled nitric oxide in chronic obstructive pulmonary disease
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Effect of nasal CPAP on exhaled nitric oxide in patients with obstructive sleep apnea
Source: Eur Respir J 2007; 30: Suppl. 51, 332s
Year: 2007

No association between exhaled nitric oxide and the outcome of the eucapnic voluntary hyperpnoea provocation test in patients suspected of exercised-induced bronchoconstriction
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014

Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013


Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Exhaled nitric oxide in children with OSAS
Source: Eur Respir J 2001; 18: Suppl. 33, 90s
Year: 2001

Exhaled nitric oxide levels in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016


Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016